[EN] ALDOSTERONE SYNTHASE INHIBITORS<br/>[FR] INHIBITEURS DE L'ALDOSTÉRONE SYNTHASE
申请人:MERCK SHARP & DOHME
公开号:WO2012012478A1
公开(公告)日:2012-01-26
The invention involves compounds of structural Formula (I) and the pharmaceutically acceptable salts thereof. The compounds of the invention are effective at selectively inhibiting CYP11B2, and are therefore useful for the treatment or prophylaxis of disorders that are associated with elevated aldosterone levels, including, but not limited to, hypertension and heart failure.
该发明涉及结构式(I)的化合物及其药用盐。该发明的化合物在选择性抑制CYP11B2方面具有有效性,因此可用于治疗或预防与升高醛固酮水平相关的疾病,包括但不限于高血压和心力衰竭。